[Clinical experiences with Synacthen Depot].
D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D003882:Dermatomyositis / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000139:chemically induced; D005500:Follow-Up Studies; D006801:Humans; D010392:Pemphigus / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy
D000324:Adrenocorticotropic Hormone
Klinische Erfahrungen mit Synacthen Depot.